Nature Biotechnology 2001 Liz Fletcher - Abstracts
| Nature Biotechnology 2001 Liz Fletcher | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Approval heralds new generation of kinase inhibitors?(Novartis' treatment for myeloid leukemia)(Brief Article) | Business | Liz Fletcher | |||
| Eli Lilly enter venture capital arena.(Statistical Data Included) | Business | Liz Fletcher | |||
| GeneMedix sets sights on Southeast Asia. | Business | Liz Fletcher | |||
| GM crops are no panacea for poverty.(starvation not significantly reduced when genetically-modified crops are grown in underdeveloped countries) | Business | Liz Fletcher | |||
| IT giants muscle into life science arena.(Abstract) | Business | Liz Fletcher | |||
| New Zealand GMO debacle undermines green lobby. | Business | Liz Fletcher | |||
| Sleeker Incyte flirts with drug discovery.(Incyte Genomics ends custom genomics and microassay unit)(Incyte Genomics Inc. ) | Business | Liz Fletcher | |||
| US stem cell policy comes under fire.(Illustration) | Business | Liz Fletcher | |||
| Vaccine tests key Alzeheimer's disease hypothesis. | Business | Liz Fletcher | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.